
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
NEUESTE BEITRÄGE
- 1
Slovakia rejects EU call to scrap higher fuel prices for foreign cars30.03.2026 - 2
Vote In favor of Your Favored Web-based Venture Stage05.06.2024 - 3
Plans for ‘stop anywhere’ night buses recommended by government for women’s safety26.03.2026 - 4
6 Well known Nissan Vehicles in the U.S.05.06.2024 - 5
Zelensky sees win for Ukraine as EU finally reaches funding deal19.12.2025
Ähnliche Artikel
'A perfect storm': Airlines cut flights and increase airfares as jet fuel price spikes30.03.2026
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.30.11.2025
The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group17.10.2023
Figure out How to Keep up with Oral Wellbeing During Pregnancy19.10.2023
How did Hugh Jackman nail his latest role? Sequins, tighty-whities and embracing 'zero embarrassment.'25.12.2025
Exploring the Mind boggling Universe of Connections: Individual Bits of knowledge25.09.2023
Exploring Programming Greatness: A Survey of \Easy to use Connection points\10.08.2023
Must-See Public Parks from Around the Globe05.06.2024
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients23.12.2025
Story of ‘first Black Briton’ rewritten by advances in ancient DNA technology19.12.2025














